<DOC>
	<DOCNO>NCT00810446</DOCNO>
	<brief_summary>The objective surveillance collect information 1 ) adverse drug reaction expect LPD ( unknown adverse drug reaction ) , 2 ) incidence adverse drug reaction surveillance , 3 ) factor consider affect safety and/or efficacy drug .</brief_summary>
	<brief_title>Safety And Efficacy Of Rifabutin In HIV Patients</brief_title>
	<detailed_description>All patient investigator prescribes first Mycobutin® register consecutively number subject reach target number order extract patient enrol investigation random .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<mesh_term>Mycobacterium avium-intracellulare Infection</mesh_term>
	<mesh_term>Rifabutin</mesh_term>
	<criteria>Patients need administer Mycobutin® order enrol surveillance . Patients administer Mycobutin® .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>